Evidence map›Paper›PMID 30889439›Full record

ArticleInternational journal for parasitology. Drugs and drug resistance2019

Resistance formation to nitro drugs in Giardia lamblia: No common markers identified by comparative proteomics.

Joachim Müller, Sophie Braga, Manfred Heller, Norbert Müller

Open access · goldAbstract readComparative Study
In one paragraph

Article in International journal for parasitology. Drugs and drug resistance, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed
3.4field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 37 citations in OpenAlex.

  1. Article
  2. Transient Adaptation ofInternational journal of molecular sciences · 2024
    Article
  3. Article
  4. Review
  5. Assessment of Drug Activities againstPathogens (Basel, Switzerland) · 2024
    Article
  6. Article
  7. Article
  8. Comparative Proteomic Analysis ofInternational journal of molecular sciences · 2023
    Article
  9. Article
  10. Review
  11. Characterization of Metronidazole-ResistantFrontiers in microbiology · 2022
    Article
  12. Article
  13. Nitroreductase Activites inPathogens (Basel, Switzerland) · 2021
    Article
  14. Article
  15. Antibacterial Discovery: 21st Century Challenges.Antibiotics (Basel, Switzerland) · 2020
    Article
  16. Article
  17. Article
  18. Article
  19. Genetic Diversity of the Flavohemoprotein Gene ofInfection and drug resistance · 2020
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Joachim MüllerInstitute of Parasitology, Vetsuisse Faculty, University of Berne, Länggass-Strasse 122, CH-3012, Berne, Switzerland. Electronic address: joachim.mueller@vetsuisse.unibe.ch.
Sophie BragaProteomics & Mass Spectrometry Core Facility, Department for BioMedical Research (DBMR), University of Berne, Freiburgstrasse 15, CH-3010, Berne, Switzerland. Electronic address: sophie.braga@dbmr.unibe.ch.
Manfred HellerProteomics & Mass Spectrometry Core Facility, Department for BioMedical Research (DBMR), University of Berne, Freiburgstrasse 15, CH-3010, Berne, Switzerland. Electronic address: manfred.heller@dbmr.unibe.ch.
Norbert MüllerInstitute of Parasitology, Vetsuisse Faculty, University of Berne, Länggass-Strasse 122, CH-3012, Berne, Switzerland. Electronic address: norbert.mueller@vetsuisse.unibe.ch.
University of Bern · CH

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In order to elucidate the question whether resistance to nitro drugs in G. lamblia is due to common resistance markers, trophozoites of three resistant G. lamblia strains, namely C4, 1062ID10, and 713M3 were grown in the presence of the two nitro drugs metronidazole and nitazoxanide and compared to their corresponding wild-types WBC6, 106, and 713 by mass spectometry shotgun analysis of their proteomes. Depending on the strain and the nitro drug, more than 200 to 500 differentially expressed proteins were identified, but there were no common patterns across strains and drugs. All resistant strains underwent antigenic variation with distinct surface antigens like variant surface proteins or cysteine rich proteins depending on strain and nitro compound. A closer look on enzymes involved in nitroreduction and detoxification of nitro radicals, NO or O

Indexed as

Drug Resistance, MultipleProteomicsAntigenic VariationAntiprotozoal AgentsGenetic MarkersGiardia lambliaNitro CompoundsParasitic Sensitivity TestsAntiprotozoal AgentsGenetic MarkersNitro CompoundsAdaptationDrug susceptibilityResistanceTolerance

Identifiers

PMID30889439
PMCPMC6423486
OpenAlexW2921344653

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.